Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 31 Issue 8, August 2013

Editorial

  • An international alliance to enable secure sharing of human genomic and clinical data merits both broad support and financial backing from the global research and clinical communities.

    Editorial

    Advertisement

Top of page ⤴

News

Top of page ⤴

Data Page

Top of page ⤴

News Feature

Top of page ⤴

Bioentrepreneur

  • Throwing some light on the Byzantine rules surrounding stock options and other equity associated with startups.

    • John J Cannon III
    • Mark Kessel
    Bioentrepreneur
Top of page ⤴

Correspondence

Top of page ⤴

Case Study

  • In a land where drugs for ultra-rare indications are the new blockbusters, Alexion's Soliris is king.

    • Brady Huggett
    Case Study
Top of page ⤴

Feature

Top of page ⤴

Patents

Top of page ⤴

News & Views

  • The erroneous links in networks inferred from data can be efficiently eliminated under certain conditions.

    • Babak Alipanahi
    • Brendan J Frey
    News & Views
  • Extensive metabolic engineering of the yeast Yarrowia lipolytica results in a sustainable and commercially viable alternative to fish oil for the supply of eicosapentaenoic acid.

    • James P Wynn
    News & Views
  • Efficient human nuclear-transfer embryo cloning is here at last, prompting renewed efforts to explore hidden variables in the cloning process.

    • Anthony C F Perry
    News & Views
Top of page ⤴

Analysis

Top of page ⤴

Article

Top of page ⤴

Letter

Top of page ⤴

Resource

Top of page ⤴

Careers and Recruitment

Top of page ⤴

Search

Quick links